- ASX200 is 0.66% higher at 6752.3.
- AnteoTech surges on COVID-19 rapid test review results.
- Csl gains TGA approval to manufacture AstraZeneca vaccine.
The tech sector is trading in the green today with gains for Afterpay, EML Payments and Technology One offsetting Altium and Appen?s losses.
The Australian market is higher today as Crown Resorts fuels the consumer discretionary sector following an $8bn takeover bid from Blackstone.
Health stocks are also higher today with Polynovo up nearly 4%, while Sonic Healthcare and Csl climbing nearly 3%.
Bitcoin is trending downward, trading at US$56,954.04 at 2pm AEDT, shedding 1.13% in the last 24-hours.
Australian-based nanotech company AnteoTech is soaring after releasing an update about its rapid COVID-19 test. Its Antigen Rapid Test achieved sensitivity of 97.3% and specificity of 99.6% as reviewed by the Victorian Infectious Diseases Reference Laboratory with such results now forming the basis of AnteoTech?s CE Mark submission.
In the headlines, Csl has gained TGA approval to manufacture AstraZeneca?s COVID-19 vaccine in Australia, but production doesn't have the green light yet as the regulator still needs to ensure vaccine batch documents and test doses meet manufacturing standards.
And former President Donald Trump is planning a social media comeback in the coming months. He plans to launch his own social networking platform which he deems will ?completely redefine the game? after being suspended from Facebook and Twitter following the riots on the Capitol on January 6th.